If you live with diabetes, it is understandable to want a simple answer to the question, “What blood sugar should I aim for?”
For many adults, there are well-established treatment targets. However, I always remind my patients that these are general goals, not one-size-fits-all rules. Your safest target depends on your age, type and duration of diabetes, medicines, risk of hypoglycemia, pregnancy status, kidney or heart disease, and overall health.
The goal is not to keep glucose at one perfect number all day. It is to remain within a safe range as consistently as possible while avoiding prolonged high blood sugar and unnecessary low blood sugar.
For many nonpregnant adults with diabetes, commonly used treatment goals are:
| Measurement | Common target | What it means |
|---|---|---|
| Before meals | 80–130 mg/dL (4.4–7.2 mmol/L) |
A common premeal target for many nonpregnant adults |
| Peak after meals | Below 180 mg/dL (below 10.0 mmol/L) |
Usually assessed 1–2 hours after the beginning of the meal |
| A1C | Below 7% (below 53 mmol/mol) |
A common longer-term goal when it can be reached safely |
An acceptable blood glucose level is not necessarily the same as a “normal” glucose level in someone without diabetes.
When we set a diabetes target, we balance two priorities: keeping glucose low enough to reduce the risk of long-term complications while avoiding hypoglycemia and treatment that is too aggressive for the individual patient.
A single blood glucose reading does not provide a complete picture of diabetes control. In clinical practice, I consider the broader pattern, including fasting and premeal glucose levels, post-meal readings when appropriate, A1C, episodes of hypoglycemia, symptoms, current medications, and, when available, continuous glucose monitoring (CGM) data. These measures should also be interpreted in the context of established blood glucose and A1C ranges for normal glucose, prediabetes, and diabetes.
For many nonpregnant adults with diabetes, a common target before meals is 80–130 mg/dL (4.4–7.2 mmol/L).
This gives us useful information about your baseline glucose before food begins to raise it. If most of your premeal readings are within your agreed target, that is encouraging, but they should still be interpreted together with your post-meal pattern, A1C, low-glucose episodes and overall treatment plan.
A reading of 80 mg/dL is not hypoglycemia. It is near the lower end of the usual premeal target. Hypoglycemia is generally defined as glucose below 70 mg/dL.
If fasting or premeal readings are repeatedly above your personal target, possible contributors include overnight glucose production, meal or medication timing, illness, poor sleep, stress and changes in physical activity. A pattern over several days is more informative than one isolated morning reading.
If morning glucose is your main concern, see our guide to fasting blood sugar levels.
For many adults with diabetes, a common target is a peak post-meal glucose below 180 mg/dL (10.0 mmol/L).
When post-meal glucose is being assessed, it is generally measured 1–2 hours after the beginning of the meal. The timing matters because this period is intended to capture glucose near its post-meal peak.
One reading slightly above 180 mg/dL does not necessarily mean your treatment is failing. A larger meal, more carbohydrate than usual, illness, stress, poor sleep or reduced activity can all affect the result. More important questions are whether higher readings occur frequently, remain elevated for a long time, or appear alongside an A1C or CGM pattern showing excessive glucose exposure.
Because blood glucose changes throughout the day, the timing of a measurement matters, particularly when interpreting blood sugar levels after eating.
Daily readings show what your blood sugar is doing at a particular moment. A1C provides a broader view of glucose exposure over the previous two to three months, with more recent weeks contributing more to the result.
For many nonpregnant adults with diabetes, a common A1C goal is below 7% (53 mmol/mol) when it can be achieved safely. Some people may benefit from a lower goal. Others need a less stringent goal because hypoglycemia, frailty, serious comorbidities, cognitive or functional limitations, or treatment burden makes tighter control less safe.
I would not interpret A1C in isolation. Two people can have the same A1C while experiencing very different patterns of highs and lows.
Learn more in A1C vs Blood Sugar, or use our HbA1c to Average Glucose Calculator.
A continuous glucose monitor, or CGM, helps us look beyond individual fingerstick readings. It shows how much time glucose spends within, above and below the target range.
| CGM metric | Common goal for many adults |
|---|---|
| Time in range: 70–180 mg/dL | More than 70% of the time |
| Time below 70 mg/dL | Less than 4% of the time |
| Time below 54 mg/dL | Less than 1% of the time |
| Time above 180 mg/dL | Less than 25% of the time |
CGM goals also need to be individualized. Some older adults with complex health problems, for example, may need more permissive goals to reduce the risk of hypoglycemia.
There is no single bedtime glucose target appropriate for every adult with diabetes. Bedtime goals depend on insulin use, risk of overnight hypoglycemia, age, other medical conditions, recent exercise, meal timing and the treatment plan you follow.
If you use insulin or medicines that can cause hypoglycemia, your clinician may give you a specific bedtime target. Follow that individualized plan rather than relying on a universal bedtime number from the internet.
For people with diabetes, glucose below 70 mg/dL (3.9 mmol/L) is considered hypoglycemia and should be taken seriously. A level below 54 mg/dL (3.0 mmol/L) is more clinically significant.
Symptoms may include shakiness, sweating, hunger, palpitations, dizziness, weakness, irritability, confusion or difficulty concentrating. If you have a hypoglycemia treatment plan, follow it promptly. Frequent low readings require medical review because medication dose, meal timing or activity may need adjustment.
I would not give exactly the same glucose goal to every patient. Your targets may need to be individualized if you:
An older adult who is otherwise healthy may still have relatively tight glucose goals. Someone with frailty, several serious illnesses or recurrent hypoglycemia may need more relaxed targets because preventing low blood sugar becomes the greater priority.
Even when your treatment plan has not changed, glucose can vary from day to day. Common influences include:
This is why I encourage patients to look for patterns rather than reacting strongly to one unusual result.
Keeping glucose in range does not require perfect numbers every day. The practical goal is to make the overall pattern safer and more consistent. Depending on your treatment plan, helpful steps may include:
Do not change insulin or medication doses because of one unusual result unless your healthcare professional has given you a specific adjustment plan.
When a patient asks whether a blood sugar number is “acceptable,” I first ask when it was measured and what target we agreed on for that person.
A premeal glucose of 125 mg/dL may be within the usual target for many adults with diabetes. The same number means something different if we are discussing a fasting laboratory test used to screen a person who has not been diagnosed with diabetes.
I also do not judge diabetes control from one good reading or one bad reading. I want to know whether most values are reasonably close to target, whether there are repeated highs, whether low glucose is occurring, and whether the A1C or CGM report tells the same story.
The best target is not the lowest number you can achieve. It is the range that offers meaningful long-term protection while remaining safe and realistic for your health and treatment.
Contact your healthcare team if:
It depends on when it was measured. For many nonpregnant adults, 130 mg/dL is at the upper end of the common premeal target. After a meal, it may also be within an acceptable range, but your individual target may differ.
For many adults with diabetes, the common goal is a peak post-meal glucose below 180 mg/dL, assessed 1–2 hours after the beginning of the meal. Frequent readings at or above this level should be reviewed as a pattern.
Seventy mg/dL is the threshold at which we become concerned about hypoglycemia. A reading below 70 mg/dL should be treated according to your diabetes plan, and repeated lows should be discussed with your healthcare team.
No. Age, pregnancy, medications, hypoglycemia risk, kidney or heart disease, functional status and other health conditions can all affect the safest goal.
There is no universal bedtime target for every adult with diabetes. Your bedtime goal should reflect your treatment plan, especially if you use insulin or are at risk of overnight hypoglycemia.
No. Below 7% is a common goal for many nonpregnant adults, but some people may benefit from a lower goal and others need a less stringent one for safety.
For many nonpregnant adults with diabetes, common treatment goals are 80–130 mg/dL before meals, below 180 mg/dL at the peak after meals, and A1C below 7% when these goals can be achieved safely.
If you use CGM, spending more than 70% of the time between 70 and 180 mg/dL is a common goal for many adults, while time below 70 mg/dL should remain limited.
Most importantly, your target should fit you. A safe plan balances glucose control with your risk of hypoglycemia, medications, age, other medical conditions and daily life. I would rather see a patient follow a realistic, individualized target safely and consistently than chase a “perfect” number that creates unnecessary risk.
Medical disclaimer: This information is for general education and does not replace professional medical advice, diagnosis or treatment. Follow the glucose targets and treatment plan recommended by your healthcare professional. Do not change insulin or diabetes medication doses without appropriate medical guidance.
Written by: Dr. Albana Greca Sejdini, MD, MMedSc
Medically reviewed by: Dr. Ruden Cakoni, MD, Endocrinologist
Last medically reviewed: July 2026
Cinnamon is a flavorful spice that can help reduce the need for sugar in oatmeal, yogurt, fruit, coffee, tea, and savory dishes. It has also been studied as a supplement for fasting glucose, HbA1c, insulin resistance, cholesterol, and weight. The findings are inconsistent, and cinnamon is not an established diabetes treatment.
Cinnamon is not a dependable treatment for high blood sugar. Some randomized trials and meta-analyses report small average improvements in fasting glucose, HbA1c, or insulin-resistance markers. Others find no meaningful effect.
A 2024 meta-analysis of 24 randomized trials reported statistically significant improvements in fasting glucose, post-meal glucose, HbA1c, and insulin-resistance estimates. However, statistical significance does not automatically mean that the change is large enough to alter treatment or prevent complications.
The National Center for Complementary and Integrative Health concludes that it remains unclear whether cinnamon supplementation is helpful for diabetes or weight loss. The ADA does not recommend herbs or supplements for glycemic benefit when effectiveness and safety have not been established adequately.
Trials have not tested one standardized cinnamon product. Important differences include:
A pooled result describes an average across studies. It cannot predict whether an individual patient will respond, which product produced the effect, whether the benefit will continue, or whether long-term complications will be reduced.
For the complete research discussion, read Cinnamon and Diabetes: Benefits, Safety, and Evidence.
Cell and animal experiments have investigated whether cinnamon compounds may affect:
Older reports described water-soluble cinnamon polyphenols as having “insulin-like” activity and sometimes used names such as MHCP. These laboratory findings do not establish that cinnamon mimics injected insulin in the human body or that it makes insulin receptors work at a clinically predictable level.
The claim that cinnamon stimulates the pancreas to produce insulin is also not established as a treatment effect in people. Human evidence does not justify using cinnamon to restore beta-cell function or replace medication.
Small human studies have produced inconsistent findings depending on the meal and cinnamon dose. One study found that 3 grams changed insulin and GLP-1 responses without significantly lowering blood glucose. Another small study reported delayed gastric emptying and a lower post-meal glucose response.
This is not strong enough to recommend cinnamon as a treatment for post-meal hyperglycemia. Delayed gastric emptying would also not automatically be desirable in someone with diabetic gastroparesis.
| Feature | Cassia-type cinnamon | Ceylon cinnamon |
|---|---|---|
| Common names | Cassia, Chinese, Indonesian/Korintje, or Vietnamese/Saigon cinnamon | Ceylon or “true” cinnamon |
| Botanical examples | C. cassia, C. burmannii, or C. loureiroi | C. verum |
| Typical flavor | Stronger, hotter, and commonly sold | Milder and more delicate |
| Stick appearance | Usually thicker, harder bark with fewer curled layers | Usually thin, fragile bark with multiple rolled layers |
| Coumarin | Often substantially higher, but highly variable | Usually much lower, but not guaranteed to be zero |
Color, flavor, and hardness may offer clues but cannot verify the species of ground cinnamon. Read the package for the botanical name. “Sweet cinnamon” is not a reliable scientific identification.
Ceylon cinnamon is generally the lower-coumarin choice for frequent culinary use. That does not prove that a Ceylon supplement lowers glucose or that every Ceylon product is safe, pure, or accurately labeled.
Coumarin is a naturally occurring plant compound found in varying amounts in cinnamon. High or prolonged intake can harm the liver in susceptible people.
The European tolerable daily intake for coumarin is:
The German Federal Institute for Risk Assessment states that an adult weighing 60 kg may reach this limit with approximately 2 grams of Cassia cinnamon containing an average coumarin concentration. Actual products vary, so this is not a precise safe-dose calculation for a package in your kitchen.
The old percentages of 5% coumarin in Cassia and 0.004% in Ceylon should not be used as fixed values. Coumarin content varies widely by species, source, batch, processing, and testing method.
Germany has not generally prohibited importing or using Cassia cinnamon. German and European authorities regulate coumarin in certain foods and advise moderation when Cassia cinnamon is consumed regularly.
| Culinary cinnamon | Capsule, extract, or “blood sugar blend” |
|---|---|
| Used in small amounts for flavor | May provide several grams or a concentrated extract daily |
| Can help replace sugar or sweet syrups | Marketed as a therapeutic product despite uncertain benefit |
| Usually part of a meal | May be taken fasting or with several other active ingredients |
| Lower exposure in ordinary use | Greater concern about coumarin, contamination, side effects, and interactions |
A supplement label may say “cinnamon bark,” “cinnamon complex,” or “proprietary blend” without clearly identifying the species or coumarin concentration. Some products combine cinnamon with bitter melon, fenugreek, chromium, berberine, gymnema, or other ingredients.
Do not combine several purported glucose-lowering supplements to increase the effect. The combination has not been proven superior and makes adverse effects, hypoglycemia, interactions, and liver problems harder to identify.
No. Studies have used different powders, extracts, species, and daily quantities. This prevents one evidence-based therapeutic dose from being recommended.
Amounts used in studies are not automatically safe for long-term self-treatment. A dose may have:
Using a small amount as a spice is different from swallowing teaspoons or capsules every day. Do not interpret the BfR example of 2 grams of average Cassia cinnamon as a recommended dose—it illustrates how easily a 60-kg adult might reach the coumarin tolerable intake.
Cinnamon can add flavor without added sugar. Practical uses include:
Cinnamon does not neutralize carbohydrate. Oatmeal, fruit, milk, baked goods, honey, and sweetened drinks still contribute to the meal’s carbohydrate and calorie total.
Never swallow dry cinnamon powder. It can be inhaled into the lungs, cause choking, irritate the airway, and lead to serious injury.
Cinnamon tea can be prepared for flavor, but it has not been shown to provide a standardized glucose-lowering dose.
A simple preparation is:
Honey is still added sugar. One teaspoon contains carbohydrate and can raise glucose. Calling honey “natural” does not make it glucose-free.
Repeated daily tea made from large amounts of Cassia cinnamon can increase coumarin exposure. Ceylon cinnamon generally contains less coumarin, but the tea still should not replace diabetes treatment.
Cinnamon used in food is usually well tolerated. Larger amounts, concentrated products, essential oil, or prolonged use may cause:
Cinnamon essential oil is highly concentrated and can irritate the mouth, skin, stomach, and airway. It should not be swallowed as a diabetes remedy.
Pregnant or breastfeeding patients, children, people with liver disease, and anyone preparing for surgery should avoid medicinal-dose cinnamon unless a qualified clinician has reviewed the specific product.
Possible concerns include:
Brewed cinnamon tea or a small spice amount is less concentrated than a supplement, but patients should still disclose regular use when liver disease, anticoagulation, pregnancy, or complex treatment is present.
A home comparison cannot prove medical effectiveness, but it can show whether a specific meal pattern is changing.
A better glucose result after cinnamon may reflect less added sugar, a smaller portion, more activity, normal meter variation, or a different starting glucose—not necessarily a pharmacologic effect.
Use the blood sugar log sheet and review after-meal blood sugar interpretation.
No clinical trial has established cinnamon as a way to prevent heart attack, stroke, kidney disease, retinopathy, neuropathy, or diabetic foot disease.
Complication prevention depends on:
Cinnamon can be part of enjoyable food. It should not distract from treatments with proven clinical benefits.
There is no predictable time. Cinnamon is not a rescue treatment for a high glucose reading, and one serving should not be expected to produce a reliable change.
No species has been proven best for glucose control. Ceylon cinnamon is generally preferred for frequent culinary use because it usually contains much less coumarin than Cassia.
There is no guideline-approved diabetes dose. Small food amounts are different from medicinal daily dosing. Do not use the amounts in research trials or supplement marketing as personal instructions.
Some pooled analyses report a small average reduction, while other evidence is inconclusive. The effect is not predictable enough to replace standard treatment.
Laboratory research has explored pancreatic and insulin-signaling effects, but a reliable increase in human insulin production has not been established as a treatment.
Small food amounts are not a common cause. Concentrated products combined with insulin, sulfonylureas, meglitinides, fasting, or several supplements may make glucose changes harder to predict.
Honey adds sugar and carbohydrate. Cinnamon does not cancel the glucose effect of honey.
The combination is not proven superior and may add side effects or glucose-lowering uncertainty. Review both products and your medicines with a clinician or pharmacist.
Medical disclaimer: This page provides general education and does not recommend a cinnamon supplement, therapeutic dose, or medication change. Do not replace insulin or diabetes medicine with cinnamon, herbs, or supplements. Seek urgent care for severe high or low glucose, ketones, vomiting, deep breathing, confusion, seizure, unconsciousness, or another emergency.